These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1991815)

  • 1. Correlation between serum osteocalcin and 24,25-dihydroxyvitamin D levels in Paget's disease of bone.
    Castro-Errecaborde N; de la Piedra C; Rapado A; Alvarez-Arroyo MV; Torres R; Traba ML
    J Clin Endocrinol Metab; 1991 Feb; 72(2):462-6. PubMed ID: 1991815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteocalcin and urinary hydroxyproline/creatinine ratio in the differential diagnosis of primary hyperparathyroidism and hypercalcaemia of malignancy.
    de la Piedra C; Toural V; Rapado A
    Scand J Clin Lab Invest; 1987 Oct; 47(6):587-92. PubMed ID: 3499657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in vitamin D metabolites during treatment of Paget's disease of bone with calcitonin or etidronate.
    Devlin RD; Gutteridge DH; Prince RL; Retallack RW; Worth GK
    J Bone Miner Res; 1990 Nov; 5(11):1121-6. PubMed ID: 2125401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteocalcin and bone remodelling in Paget's disease of bone, primary hyperparathyroidism, hypercalcaemia of malignancy and involutional osteoporosis.
    Torres R; de la Piedra C; Rapado A
    Scand J Clin Lab Invest; 1989 May; 49(3):279-85. PubMed ID: 2787049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The correlation between the serum levels of osteocalcin and 24,25-dihydroxyvitamin D in Paget's disease of bone].
    Castro Errecarborde N; de la Piedra Gordo C; Rapado Errazti A
    An Med Interna; 1990 Jun; 7(6):286-90. PubMed ID: 2102732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D status in Paget's bone disease. Effects of calcitonin therapy.
    Nunziata V; Giannattasio R; di Giovanni G; Lettera AM; Nunziata CA
    Clin Orthop Relat Res; 1993 Aug; (293):366-71. PubMed ID: 8339504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical usefulness of serum tartrate-resistant acid phosphatase in Paget's disease of bone: correlation with other biochemical markers of bone remodelling.
    Torres R; de la Piedra C; Rapado A
    Calcif Tissue Int; 1991 Jul; 49(1):14-6. PubMed ID: 1893290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Decrease of the coefficient of intestinal calcium absorption with normal blood levels of 1,25-dihydroxyvitamin D and decreasing levels of 24,25-dihydroxyvitamin D in Paget's disease of bone].
    Traba ML; Climent P; Rapado A; de la Piedra C; Díaz Curiel M
    Rev Clin Esp; 1986 Nov; 179(8):401-3. PubMed ID: 3494277
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone.
    Delmas PD; Demiaux B; Malaval L; Chapuy MC; Meunier PJ
    Calcif Tissue Int; 1986 Jan; 38(1):60-1. PubMed ID: 3079654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related changes in vitamin D metabolites, osteocalcin, alkaline phosphatase and parathyrin in normal Chinese women in Taipei.
    Tsai KS; Chen JS; Hwang KM; Chieng PU; Su CT
    J Formos Med Assoc; 1991 Nov; 90(11):1033-7. PubMed ID: 1687046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone.
    Kaddam IM; Iqbal SJ; Holland S; Wong M; Manning D
    Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():327-30. PubMed ID: 7979096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal vitamin D metabolism in Paget's disease of bone.
    Guillard-Cumming DF; Beard DJ; Douglas DL; Johnson SK; Lawson-Matthew PJ; Russell RG; Kanis JA
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):559-66. PubMed ID: 3872746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risedronate, a highly effective oral agent in the treatment of patients with severe Paget's disease.
    Singer FR; Clemens TL; Eusebio RA; Bekker PJ
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1906-10. PubMed ID: 9626117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of serum osteocalcin to hydroxyapatite in Paget's disease of bone.
    Torres R; de la Piedra C; Rapado A
    Bone Miner; 1991 Jul; 14(1):55-65. PubMed ID: 1868269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gautvik KM; Gordeladze JO
    Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum osteocalcin in Paget's disease of bone: basal concentrations and response to bisphosphonate treatment.
    Papapoulos SE; Frolich M; Mudde AH; Harinck HI; vd Berg H; Bijvoet OL
    J Clin Endocrinol Metab; 1987 Jul; 65(1):89-94. PubMed ID: 3495547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum osteocalcin and vitamin D in postmenopausal diabetic azotemics.
    Lu KC; Shieh SD; Chyr SH; Lin SH; Li BL; Diang LK; Chen WQ; Lin YF
    Diabetes Res; 1993; 22(3):97-104. PubMed ID: 8076446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid function in Paget's disease of bone.
    Siris ES; Clemens TP; McMahon D; Gordon A; Jacobs TP; Canfield RE
    J Bone Miner Res; 1989 Feb; 4(1):75-9. PubMed ID: 2718781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term elevation of 1,25-dihydroxyvitamin D after short-term intravenous administration of pamidronate (aminohydroxypropylidene bisphosphonate, APD) in Paget's disease of bone.
    Devlin RD; Retallack RW; Fenton AJ; Grill V; Gutteridge DH; Kent GN; Prince RL; Worth GK
    J Bone Miner Res; 1994 Jan; 9(1):81-5. PubMed ID: 8154313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.